firing up my L2's
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
okie dokie...boy what a move in UVXY!
Jhook? like an inverted one for the selloff?
$SPX how's that for a quick flush ? link back for 60
bombastic! early bird gets da worm every time
Art Cashin talking about Spain riots and increasing animosity in China against Japanese businesses...could get crazy today
Kass underwater on his SPY short yesterday ...poor guy
Gapper ROSG momo
QCOR lol, yeah now watch it open UNCH
ham already picked HEB
OT: I think it's kinda funny. Having fun at a dictator's expense sounds like a riot. But yeah, overall, scary situation in da ME.
Kass digging in his heels on his short position...maybe he doesn't get buried this time? lol
@DougKass
Adding to my SPY short at 145.7 now
Investor Gold Buying to Resume & Fed Doubling Their Balance Sheet AGAIN!
September 24th, 2012 at 10:46 am
A leading precious metals consultancy, Thomson Reuters GFMS, has forecast that investors will buy record amounts of gold in the remainder of 2012. GFMS produces the benchmark supply and demand statistics for the gold market. GFMS forecasts that investors will purchase 973 tons of gold in the second half of 2012, more than during the wild gold market of the summer of 2011. This surge in demand for the yellow metal, GFMS says, will move gold above the $1850 an ounce level, not far from the record high of $1920 hit in September 2011.
GFMS may be right. This past week, gold hit its high for this year at $1790 an ounce on the back of the various global stimulus plans launched by a number of countries around the globe. Primary among the recently announced stimulus plans was the Federal Reserve’s QE3 or as some in the market have called it, QE infinity. Philip Klapwijk of GFMS said that, for the gold market, “QE3 has become talismanic”.
The Federal Reserve said it would purchase $40 billion a month in mortgage-backed securities indefinitely. In addition, the Fed will continue Operation Twist – the buying of longer-dated U.S. treasury notes and bonds. When all is totaled, the market is looking at about $85 billion a month in government bond purchases for an unlimited period of time.
The main characteristic of QE3 that drives the gold market is the fact that the open-ended purchases of all of these Treasuries will be financed by money that does not yet exist! And it’s not just about a fear of future inflation being ignited by all this money creation. It’s a very logical move higher by gold based on recent history of Fed actions and gold prices.
Even ignoring Operation Twist, the Fed will add $40 billion a month, or $480 billion a year, to its balance sheet. If one looks at the Fed’s own website, you will see that it shows current assets of $2.8 trillion. Add $480 billion annually to that and in about five years the Fed’s assets (the foundation of the money supply) will have nearly doubled.
That is exactly what happened in the last five years too…the Fed’s assets doubled. And in what should not be a surprise to gold investors, the price of gold also doubled! For the past decade or so, gold has tracked the increase in Federal Reserve’s assets. Do not be shocked if that pattern continues over the next five or ten years too.
http://www.thetechnicaltraders.com/272-6.html
Investor Gold Buying to Resume & Fed Doubling Their Balance Sheet AGAIN!
September 24th, 2012 at 10:46 am
A leading precious metals consultancy, Thomson Reuters GFMS, has forecast that investors will buy record amounts of gold in the remainder of 2012. GFMS produces the benchmark supply and demand statistics for the gold market. GFMS forecasts that investors will purchase 973 tons of gold in the second half of 2012, more than during the wild gold market of the summer of 2011. This surge in demand for the yellow metal, GFMS says, will move gold above the $1850 an ounce level, not far from the record high of $1920 hit in September 2011.
GFMS may be right. This past week, gold hit its high for this year at $1790 an ounce on the back of the various global stimulus plans launched by a number of countries around the globe. Primary among the recently announced stimulus plans was the Federal Reserve’s QE3 or as some in the market have called it, QE infinity. Philip Klapwijk of GFMS said that, for the gold market, “QE3 has become talismanic”.
The Federal Reserve said it would purchase $40 billion a month in mortgage-backed securities indefinitely. In addition, the Fed will continue Operation Twist – the buying of longer-dated U.S. treasury notes and bonds. When all is totaled, the market is looking at about $85 billion a month in government bond purchases for an unlimited period of time.
The main characteristic of QE3 that drives the gold market is the fact that the open-ended purchases of all of these Treasuries will be financed by money that does not yet exist! And it’s not just about a fear of future inflation being ignited by all this money creation. It’s a very logical move higher by gold based on recent history of Fed actions and gold prices.
Even ignoring Operation Twist, the Fed will add $40 billion a month, or $480 billion a year, to its balance sheet. If one looks at the Fed’s own website, you will see that it shows current assets of $2.8 trillion. Add $480 billion annually to that and in about five years the Fed’s assets (the foundation of the money supply) will have nearly doubled.
That is exactly what happened in the last five years too…the Fed’s assets doubled. And in what should not be a surprise to gold investors, the price of gold also doubled! For the past decade or so, gold has tracked the increase in Federal Reserve’s assets. Do not be shocked if that pattern continues over the next five or ten years too.
http://www.thetechnicaltraders.com/272-6.html
Tanker QCOR more carnage imo
thanks all, nice to start the week with a juicy win
Gapper PPHM wow look at that short covering!
hmmm yeah you are prolly on to somethin there...GOOG prolly should be a 1000 dollar stock and AAPL has been parabolic for a couple years now...catchup time imo
PPHM yowzers down big on this:
Peregrine Pharmaceuticals Announces That It Has Discovered Major Discrepancies in
Treatment Group Coding by an Independent Third-Party Vendor Responsible for
Distribution of Blinded Investigational Product Used in Its Bavituximab Phase II
Second-Line Non-Small Cell Lung Cancer Trial
The Company Is Currently Conducting a Detailed Review, Including Assessing Its
Impact on Overall Trial Results; Investors Should Not Rely on Previously Reported
Clinical Data Disclosed From This Phase II Trial at This Time; These Recent
Findings Do Not Impact Other Ongoing Bavituximab Clinical Trials
TUSTIN, CA, Sep 24, 2012 (MARKETWIRE via COMTEX) -- Peregrine Pharmaceuticals
(PPHM) announced today that during the course of preparing for an end-of-phase II
meeting with regulatory authorities and following recent data announcements from
its randomized, double-blind placebo-controlled Phase II trial of bavituximab in
second-line non-small cell lung cancer, it discovered major discrepancies between
some patient sample test results and patient treatment code assignments. Due to
the double-blind nature of the trial, Peregrine was not permitted to have access
to either patient group assignments or related product coding information. As
part of the trial's execution, Peregrine contracted with independent third-party
contractors to execute treatment group assignments and oversee clinical trial
material coding and distribution according to established procedures. A
subsequent review of information has determined that the source of these
discrepancies appear to have been associated with the independent third-party
contracted to code and distribute investigational drug product.
This discrepancy is specific to this trial and will have no impact on other
ongoing bavituximab trials.
Peregrine intends to communicate further as soon as it is able to determine the
impact of this issue. In the meantime, investors should not rely on clinical data
that the company disclosed on or before September 7, 2012 from its Phase II
bavituximab trial in patients with second-line non-small cell lung cancer or any
presentations or other documents related to this Phase II trial.
Welcome back. Ham is kicking some serious tail lately...may turn into a race for 2nd place imo
Not like it matters to the liberal Democrats. Obama is going to win and the amount of money we are spending now on "save da erf" crap is gonna look small come this time next year.
Tanker QCOR looking weak into the close, chart1back
Chanos was on CNBC yesterday and he is shorting China, I was out but did see the headlines on my iphone...mainly posted this as a reminder to myself to see what he said
VVUS: interesting, I guess ARNA might get approval from EU ppl..or maybe they decline all US fat pills lol
Tanker BVSN just a guess on momo volatility
Gapper CTAS earnings amc
Tanker BIOF same logic as ham from yesterday
Gapper QCOR on analysts defending
Respectfully decline...wacky schedule here! But I could pinch hit every now and again
UVXY new lows again today? I won't mind. chart 1 back
True. I figure he might be due though...he streaky.